Nezihe C Goksenoglu
Research Subjects
Research Interests
Nezihe C Goksenoglu has a total of 11 co-authors. Here are the top co-authors by number of shared publications:
- Can Yucel Karabay
Cardiology Clinic, Kartal Kosuyolu Heart and Research Hospital, Istanbul, Turkey
1 shared publication - Cuneyt Salturk
Department of Chest Diseases, Medipol University Faculty of Medicine, İstanbul, Türkiye
1 shared publication - Feyza Kargın
Respiratory and Intensive Care Unit, Sureyyapaşa Chest Diseases and Thoracic Surgery Training and Research Hospital, Soyak Yenişehir Manolya Evleri, 34770 Umraniye, Istanbul, Turkey
1 shared publication - Gökay Güngör
Intensive Care Unit, University of Health Sciences, Sureyyapasa Pulmonary Disease and Pulmonary Surgery Training and Research Hospital, 34844 Istanbul, Türkiye
1 shared publication - Huriye Berk Takir
Clinics of Chest Diseases, University of Health Sciences, Istanbul Sureyyapasa Chest Diseases and Thoracic Surgery Training and Research Hospital, Istanbul, Turkey
1 shared publication - Merih Balcı
Respiratory and Intensive Care Unit, Sureyyapaşa Chest Diseases and Thoracic Surgery Training and Research Hospital, Soyak Yenişehir Manolya Evleri, 34770 Umraniye, Istanbul, Turkey
1 shared publication
Latest Publications
- Open Access
- 1 January 2014
- Published by Mattioli1885 in Multidisciplinary Respiratory Medicine
- Vol. 9 (1) , 8
The safety of beta-blocker use in chronic obstructive pulmonary disease patients with respiratory failure in the intensive care unit
The safety of beta-blockers as a heart rate-limiting drug (HRLD) in patients with acute respiratory failure (ARF) due to chronic obstructive lung disease (COPD) has not been properly assessed in the intensive care unit (ICU) setting. This study aims to compare the use of beta-blocker drugs relative to non-beta-blocker ones in COPD patients with ARF due to heart rate-limiting with respect to length of ICU stay and mortality.
- 1 January 2014
- Published by Mattioli1885 in Multidisciplinary Respiratory Medicine
- Vol. 9 (1) , 8
Open AccessThe safety of beta-blocker use in chronic obstructive pulmonary disease patients with respiratory failure in the intensive care unit
The safety of beta-blockers as a heart rate-limiting drug (HRLD) in patients with acute respiratory failure (ARF) due to chronic obstructive lung disease (COPD) has not been properly assessed in the intensive care unit (ICU) setting. This study aims to compare the use of beta-blocker drugs relative to non-beta-blocker ones in COPD patients with ARF due to heart rate-limiting with respect to length of ICU stay and mortality.